To explore the extent to which the NF-κB signaling pathway induced by Ile was involved in the intestinal barrier disruption and inflammation of colitis, the Ile gavage and DSS-induced colitis mouse model was constructed, and IKK-16 was administered to inhibit the NF-κB signaling pathway. Here, NFKB1 is linked to colitis.